Exit Notice

You are about to leave ClinicalTrials.gov and go to: A dose finding study of weekly and every-3-week nab-Paclitaxel followed by carboplatin as first-line therapy in patients with advanced non-small cell lung cancer URL: https://pubmed.ncbi.nlm.nih.gov/20521351/

Click on the link to continue or return to ClinicalTrials.gov Home